Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – Revised guidelines on the assessment and management of reproductive complications in young female cancer survivors provide the latest evidence-based recommendations for evaluation and…
Recent reports show that more people age 65 and older are dying at home rather than in a hospital. Because of this, hospice services have increased over the…
John J. Ross, MD, instructor at Harvard Medical School, author of Shakespeare’s Tremor and Orwell’s Cough: Medical Lives of Famous Writers, discusses the medical history of Jack London and…
NEW YORK (Reuters Health) – Symptomatic lymphoceles that develop after retroperitoneal lymph node dissection in gynecologic cancer patients can be dealt with safely and effectively by laparoscopic lymphocele…
Michael Chez, MD, Director of Pediatric Neurology at Sutter Health, discusses the association between inflammatory conditions in mothers and autism in their children. Dr. Chez further assesses the potential for anti-inflammatory…
Michael Chez, MD, Director of Pediatric Neurology at Sutter Health, evaluates the role that the immune system and inflammation play in autism. Dr. Chez evaluates evidence from different studies, including elevated…
NEW YORK (Reuters Health) – While the risk of prostate cancer appears to be reduced in men taking dutasteride, there are indications that cancer may emerge once the…
When it comes to understanding autism, the picture is far from complete. Michael Chez, MD, Director of Pediatric Neurology at the Sutter Health, helps demystify current trends related to…
David Sayen, Regional Manager, Centers for Medicare and Medicaid Services, discusses the shift in health insurance programs from fee-for-service to an “accountable care” model, in which incentives are…
NEW YORK (Reuters Health) – TNFerade biologic, a novel method of delivering tumor necrosis factor to tumor cells by gene transfer, does not prolong survival when added to…
